Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer’s disease pathology

dc.creatorTramutola A.
dc.creatorArena A.
dc.creatorCini C.
dc.creatorButterfield D.A.
dc.creatorBarone E.
dc.date.accessioned2020-09-02T22:29:22Z
dc.date.accessioned2022-11-08T20:18:37Z
dc.date.available2020-09-02T22:29:22Z
dc.date.available2022-11-08T20:18:37Z
dc.date.created2020-09-02T22:29:22Z
dc.date.issued2017
dc.identifier17, 1, 59-75
dc.identifier14737175
dc.identifierhttps://hdl.handle.net/20.500.12728/6432
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5142804
dc.languageen
dc.publisherTaylor and Francis Ltd
dc.subjectAlzheimer disease
dc.subjectdementia
dc.subjectGLP-1
dc.subjectincretins
dc.subjectinsulin resistance
dc.subjectantidiabetic agent
dc.subjectdipeptidyl peptidase IV inhibitor
dc.subjectglucagon like peptide 1
dc.subjectliraglutide
dc.subjectantidiabetic agent
dc.subjectglucagon like peptide 1
dc.subjectAlzheimer disease
dc.subjectamyloid plaque
dc.subjectantiinflammatory activity
dc.subjectcell regeneration
dc.subjectdisease course
dc.subjecthuman
dc.subjectinsulin resistance
dc.subjectnervous system development
dc.subjectneuroprotection
dc.subjectnonhuman
dc.subjectprotein function
dc.subjectReview
dc.subjectsignal transduction
dc.subjectsynaptogenesis
dc.subjectAlzheimer disease
dc.subjectdrug effects
dc.subjectmetabolism
dc.subjectmolecularly targeted therapy
dc.subjectsignal transduction
dc.subjectAlzheimer Disease
dc.subjectGlucagon-Like Peptide 1
dc.subjectHumans
dc.subjectHypoglycemic Agents
dc.subjectInsulin Resistance
dc.subjectMolecular Targeted Therapy
dc.subjectSignal Transduction
dc.titleModulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer’s disease pathology
dc.typeReview


Este ítem pertenece a la siguiente institución